2019年・2020年からの当教室からの発表論文を掲載しております。(First authorのみ記載)

2021年

  1. Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal. Hai Nam N. Liver Transpl. 2021 Oct 16. doi: 10.1002/lt.26336. Epub ahead of print. PMID: 34655506.
  2. Intraoperative indocyanine green imaging facilitates optimal surgical margin for colorectal liver metastasis with preoperatively undetected intrabiliary tumor growth. Seo S. J Hepatobiliary Pancreat Sci. 2021 Aug 17. doi: 10.1002/jhbp.1037. Online ahead of print. PMID: 34403558.
  3. Anatomy of the Middle Hepatic Vein Tributaries to Promote Safer Hepatic Vein-Guided Liver Resection. Ogiso S. J Gastrointest Surg. 2021 Jul 29. doi: 10.1007/s11605-021-05074-2. Online ahead of print.PMID: 34327658
  4. Learning process of laparoscopic liver resection and postoperative outcomes: chronological analysis of single-center 15-years’ experience. Yoh T. Surg Endosc. 2021 Jul 26. doi: 10.1007/s00464-021-08660-2. Online ahead of print. PMID: 34312730
  5. Muscularity Defined by the Combination of Muscle Quantity and Quality is Closely Related to Both Liver Hypertrophy and Postoperative Outcomes Following Portal Vein Embolization in Cancer Patients. Yao S. Ann Surg Oncol. 2021 Jul 31. doi: 10.1245/s10434-021-10525-w. Online ahead of print. PMID: 34333707
  6. Fluid dynamics analyses of the intrahepatic portal vein tributaries using 7-T MRI. Oshima Y. HPB (Oxford). 2021 Apr 16:S1365-182X(21)00105-2. doi: 10.1016/j.hpb.2021.04.005. Online ahead of print. PMID: 33958282
  7. A systematic review of prediction models for post-hepatectomy liver failure in patients undergoing liver surgery. Yoshino K and Yoh T. HPB (Oxford). 2021 Sep;23(9):1311-1320. doi: 10.1016/j.hpb.2021.05.002. PMID: 34090805
  8. Identifying Patients Who May Benefit from Liver Resection Compared to Living Donor Liver Transplantation for Hepatocellular Carcinoma Using 18F-FDG PET. Yoh T. World J Surg. 2021 Nov;45(11):3395-3403. doi: 10.1007/s00268-021-06235-9. PMID: 34274984
  9. Micro- and macro-borderless surgery using a newly developed high-resolution (4K) three-dimensional video system. Yagi S. PLoS One. 2021 May 12;16(5):e0250559. doi: 10.1371/journal.pone.0250559. PMID: 33979347.
  10. Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma: A Case Controlled Study with Propensity Score Matching. Uemoto Y. World J Surg. 2021 Aug;45(8):2572-2580. doi: 10.1007/s00268-021-06115-2. PMID: 33881580
  11. A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report. Kitada T. Surg Case Rep. 2021 Mar 19;7(1):72. doi: 10.1186/s40792-021-01155-1. PMID: 33742297
  12. Post-transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants. Tajima T. Liver Transpl. 2021 Aug;27(8):1165-1180. doi: 10.1002/lt.26034. PMID: 33655645
  13. Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model. Nishino H. Anticancer Res. 2021 Apr;41(4):1803-1810. doi: 10.21873/anticanres.14946.PMID: 33813385
  14. Low level of postoperative plasma antithrombin III is associated with portal vein thrombosis after liver surgery. Okuno M. Surg Today. 2021 Aug;51(8):1343-1351. doi: 10.1007/s00595-021-02257-x. PMID: 33655439
  15. Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters. Fukuyama K. PLoS One. 2021 Feb 4;16(2):e0245939. doi: 10.1371/journal.pone.0245939. PMID: 33539378
  16. Epithelial expression of Gata4 and Sox2 regulates specification of the squamous-columnar junction via MAPK/ERK signaling in mice. Sankoda N. Nat Commun. 2021 Jan 25;12(1):560. doi: 10.1038/s41467-021-20906-0. PMID: 33495473
  17. Novel mouse model for cholestasis-induced liver fibrosis resolution by cholecystojejunostomy. Yoshino K. J Gastroenterol Hepatol. 2021 Sep;36(9):2493-2500. doi: 10.1111/jgh.15406. PMID: 33448457
  18. Complement-5 Inhibition Deters Progression of Fulminant Hepatitis to Acute Liver Failure in Murine Models. Kusakabe J. Cell Mol Gastroenterol Hepatol. 2021;11(5):1351-1367. doi: 10.1016/j.jcmgh.2021.01.001. PMID: 33444818
  19. Impact of vascular abnormality on contrast-enhanced CT and high C-reactive protein levels on postoperative pancreatic hemorrhage after pancreaticoduodenectomy: A multi-institutional, retrospective analysis of 590 consecutive cases. Uchida Y. Pancreatology. 2021 Jan;21(1):263-268. doi: 10.1016/j.pan.2020.11.007. PMID: 33339724
  20. Donor-dominant one-way matching of human leukocyte antigen-A/B/DR alleles predicts graft-versus-host disease following living donor liver transplantation. Hirata M. Hepatol Res. 2021 Jan;51(1):135-148. doi: 10.1111/hepr.13579. PMID: 33034106
  21. Is 0.6% Reasonable as the Minimum Requirement of the Graft-to-recipient Weight Ratio Regardless of Lobe Selection in Adult Living-donor Liver Transplantation? Kusakabe J. Transplantation. 2021 Sep 1;105(9):2007-2017. doi: 10.1097/TP.0000000000003472.PMID: 33031228
  22. Laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma. Ogiso S. HPB (Oxford). 2021 Apr;23(4):533-537. doi: 10.1016/j.hpb.2020.08.009. PMID: 32912835
  23. What is a precise anatomic resection of the liver? Proposal of a new evaluation method in the era of fluorescence navigation surgery. Nishino H. J Hepatobiliary Pancreat Sci. 2021 Jun;28(6):479-488. doi: 10.1002/jhbp.824. PMID: 32896953
  24. The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice. Kawasoe J. Am J Transplant. 2021 Feb;21(2):540-551. doi: 10.1111/ajt.16269. PMID: 32805077
  25. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation. Kimura Y. Liver Transpl. 2021 Feb;27(3):403-415. doi: 10.1002/lt.25870. PMID: 32780942
  26. Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk? Macshut M. Clin Nutr. 2021 Mar;40(3):956-965. doi: 10.1016/j.clnu.2020.06.023. PMID: 32665100
  27. Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival. Yoh T. Ann Surg. 2021 Apr 1;273(4):792-799. doi: 10.1097/SLA.0000000000003358. PMID: 31058698

2020年

  1. Metronomic photodynamic therapy using an implantable LED device and orally administered 5-aminolevulinic acid. Kirino I. Sci Rep. 2020 Dec 16;10(1):22017. doi: 10.1038/s41598-020-79067-7. PMID: 33328544
  2. Time-frequency analysis of serum with proton nuclear magnetic resonance for diagnosis of pancreatic cancer. Sato A. Sci Rep. 2020 Dec 14;10(1):21941. doi: 10.1038/s41598-020-79087-3. PMID: 33318606
  3. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. Ishii T. World J Surg Oncol. 2020 Dec 4;18(1):319. doi: 10.1186/s12957-020-02099-w. PMID: 33276780
  4. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. Masui T. BMC Cancer. 2020 Nov 14;20(1):1104. doi: 10.1186/s12885-020-07581-y. PMID: 33189127
  5. Liver Regeneration after Hepatectomy and Partial Liver Transplantation. Yagi S. Int J Mol Sci. 2020 Nov 9;21(21):8414. doi: 10.3390/ijms21218414. PMID: 33182515.
  6. Foxp3+ Regulatory T Cells Inhibit CCl4-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity. Ikeno Y. Front Immunol. 2020 Oct 15;11:584048. doi: 10.3389/fimmu.2020.584048. PMID: 33178216
  7. Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis – a retrospective study. Nam NH. Transpl Int. 2020 Dec;33(12):1807-1820. doi: 10.1111/tri.13761. PMID: 33166011
  8. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis. Uchida Y. Surg Oncol. 2020 Dec;35:527-532. doi: 10.1016/j.suronc.2020.10.010. PMID: 33160278
  9. Eosinophilic peritonitis with colon cancer: a case report. Ataka R. BMC Gastroenterol. 2020 Oct 27;20(1):353. doi: 10.1186/s12876-020-01500-y. PMID: 33109117.
  10. Liver transplantation in patients with portal vein thrombosis: A strategic road map throughout management. Sharshar M. Surgery. 2020 Dec;168(6):1160-1168. doi: 10.1016/j.surg.2020.07.023. PMID: 32861438
  11. The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation. Tada S. Transplant Direct. 2020 Aug 12;6(9):e591. doi: 10.1097/TXD.0000000000001045. PMID: 32851124.
  12. Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients. Ito T. Int J Surg Case Rep. 2020;74:46-52. doi: 10.1016/j.ijscr.2020.07.069. PMID: 32791447
  13. Structure and surgical dissection layers of the bare area of the liver. Ishii T. BMC Surg. 2020 Jul 31;20(1):172. doi: 10.1186/s12893-020-00830-8. PMID: 32736550
  14. Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response. Yamane K. Sci Rep. 2020 Jul 21;10(1):12086. doi: 10.1038/s41598-020-69009-8. PMID: 32694579.
  15. Diagnostic potential of presepsin in bacterial infection following hepato-biliary-pancreatic surgery: A prospective observational study. Yao S. J Hepatobiliary Pancreat Sci. 2020 Oct;27(10):756-766. doi: 10.1002/jhbp.802. PMID: 32654388
  16. Effect of administration of β-hydroxy-β-methyl butyrate-enriched formula after liver transplantation: A pilot randomized controlled trial. Kamo N. Nutrition. 2020 Nov-Dec;79-80:110871. doi: 10.1016/j.nut.2020.110871. PMID: 32593895.
  17. Etiology of Liver Steatosis Influences the Severity of Ischemia/Reperfusion Injury and Survival After Liver Transplantation in Rats. Miyachi Y. Liver Transpl. 2020 Nov;26(11):1504-1515. doi: 10.1002/lt.25814. PMID: 32511857
  18. Preoperative abnormal body composition is closely related to bacteremia after living donor liver transplantation. Kamo N. Nutrition. 2020 Sep;77:110798. doi: 10.1016/j.nut.2020.110798. PMID: 32446184
  19. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade. Kusakabe J. Transplantation. 2020 Oct;104(10):2065-2077. doi: 10.1097/TP.0000000000003302. PMID: 32384381
  20. Chloroquine induces apoptosis in pancreatic neuroendocrine neoplasms via endoplasmic reticulum stress. Nakano K. Endocr Relat Cancer. 2020 Jul;27(7):431-439. doi: 10.1530/ERC-20-0028. PMID: 32369772
  21. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival. Okuno M. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):496-509. doi: 10.1002/jhbp.747. PMID: 32362018.
  22. Extent of liver resection is associated with incomplete liver restoration and splenomegaly a long period after liver resection. Nam NH. Surgery. 2020 Jul;168(1):40-48. doi: 10.1016/j.surg.2020.02.022. PMID: 32349870
  23. A nonhuman primate model of liver fibrosis towards cell therapy for liver cirrhosis. Yasuda K. Biochem Biophys Res Commun. 2020 Jun 4;526(3):661-669. doi: 10.1016/j.bbrc.2020.03.148. PMID: 32248968
  24. The combination of a male donor’s high muscle mass and quality is an independent protective factor for graft loss after living donor liver transplantation. Miyachi Y. Am J Transplant. 2020 Dec;20(12):3401-3412. doi: 10.1111/ajt.15884. PMID: 32243072
  25. Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection? Masui T. Scand J Gastroenterol. 2020 Apr;55(4):479-484. doi: 10.1080/00365521.2020.1743352. PMID: 32223573
  26. Usefulness of 18 F-FDG-PET/CT in the diagnosis and prediction of recurrence of pancreatic neuroendocrine neoplasms. Sato A. J Hepatobiliary Pancreat Sci. 2020 Jul;27(7):414-420. doi: 10.1002/jhbp.734. PMID: 32196985
  27. Transient FOXO1 inhibition in pancreatic endoderm promotes the generation of NGN3+ endocrine precursors from human iPSCs. Sasaki B. Stem Cell Res. 2020 Apr;44:101754. doi: 10.1016/j.scr.2020.101754. PMID: 32179491
  28. The Impact of Biliary Reconstruction Methods on Small Partial Liver Grafts. Yoshikawa J. Transplant Direct. 2020 Jan 13;6(2):e523. doi: 10.1097/TXD.0000000000000966. PMID: 32095509 Free PMC article.
  29. Living donor liver transplantation in situs inversus totalis with a patient-specific three-dimensional printed liver model. Ishii T. Pediatr Transplant. 2020 May;24(3):e13675. doi: 10.1111/petr.13675. PMID: 32068328
  30. Prognostic index consisting of early post-transplant variables <2 weeks in adult living-donor liver transplantation. Kusakabe J. Hepatol Res. 2020 Jun;50(6):741-753. doi: 10.1111/hepr.13489. PMID: 32012392
  31. Unexpected metastasis of intraductal papillary neoplasm of the bile duct without an invasive component to the brain and lungs: A case report. Nam NH. World J Gastroenterol. 2020 Jan 21;26(3):366-374. doi: 10.3748/wjg.v26.i3.366. PMID: 31988595.
  32. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis. Morino K. Ann Surg Oncol. 2020 Jun;27(6):1908-1917. doi: 10.1245/s10434-020-08207-0. PMID: 31939034
  33. Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Sharshar M. Surg Today. 2020 Jul;50(7):757-766. doi: 10.1007/s00595-019-01954-y. PMID: 31925578
  34. ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure. Yamamoto G. Surgery. 2020 Feb;167(2):410-416. doi: 10.1016/j.surg.2019.09.021. PMID: 31727326
  35. Long-term impact and clinical significance of living donor liver transplantation with respect to donor liver restoration and spleen size: A prospective study. Yoshino K. Am J Transplant. 2020 Mar;20(3):808-816. doi: 10.1111/ajt.15627. PMID: 31566887
  36. Anatomical Pitfall in Right Posterior Sector Graft Procurement in Living Donor Liver Transplantation. Kusakabe J. Liver Transpl. 2020 Feb;26(2):299-303. doi: 10.1002/lt.25648. PMID: 31563152
  37. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Hamaguchi Y. Clin Nutr. 2020 Jun;39(6):1885-1892. doi: 10.1016/j.clnu.2019.08.012. PMID: 31481263
  38. Combination of postoperative C-reactive protein value and computed tomography imaging can predict severe pancreatic fistula after pancreatoduodenectomy. Uchida Y. HPB (Oxford). 2020 Feb;22(2):282-288. doi: 10.1016/j.hpb.2019.06.020. PMID: 31416787
  39. Current Status of Liver Transplantation Using Marginal Grafts. Badawy A. J Invest Surg. 2020 Jul;33(6):553-564. doi: 10.1080/08941939.2018.1517197. PMID: 30457408
  40. Evans Syndrome After Successful Immunosuppressant-Free Living-Donor Liver Transplant. Badawy A. Exp Clin Transplant. 2020 Apr;18(2):258-260. doi: 10.6002/ect.2018.0005. PMID: 29911962

2019年

  1. Cholangiocarcinoma after flow diversion surgery for congenital biliary dilatation: A case report and review of literature. Ataka R. World J Hepatol. 2019 Nov 27;11(11):743-751. doi: 10.4254/wjh.v11.i11.743. PMID: 31772721
  2. Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase? Tajima T. Transplant Direct. 2019 Sep 19;5(10):e491. doi: 10.1097/TXD.0000000000000932. PMID: 31723586
  3. Assessment and significance of sarcopenia in liver transplantation. Nam NH. Clin Transplant. 2019 Dec;33(12). doi: 10.1111/ctr.13741. PMID: 31651060.
  4. A clinical pilot study of Resection Process Map: A novel virtual hepatectomy software to visualize the resection process, case series. Uchida Y. Int J Surg. 2019 Nov;71:36-40. doi: 10.1016/j.ijsu.2019.09.002. PMID: 31525504
  5. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Hamaguchi Y. Clin Nutr. 2020 Jun;39(6):1885-1892. doi: 10.1016/j.clnu.2019.08.012. PMID: 31481263
  6. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study. Yoh T. Surgery. 2019 Dec;166(6):975-982. doi: 10.1016/j.surg.2019.06.025. PMID: 31421869
  7. Combination of postoperative C-reactive protein value and computed tomography imaging can predict severe pancreatic fistula after pancreatoduodenectomy. Uchida Y. HPB (Oxford). 2020 Feb;22(2):282-288. doi: 10.1016/j.hpb.2019.06.020. PMID: 31416787
  8. Right hepatectomy with en-bloc resection of bilateral hepatic arteries for Bismuth type IIIa hilar cholangiocarcinoma: A case report. Ataka R. Asian J Surg. 2019 Dec;42(12):1021-1023. doi: 10.1016/j.asjsur.2019.07.018. PMID: 31405627.
  9. Auxiliary xenotransplantation as an in vivo bioreactor-Development of a transplantable liver graft from a tiny partial liver. Masano Y. Xenotransplantation. 2019 Nov;26(6):e12545. doi: 10.1111/xen.12545. PMID: 31400029
  10. Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best? Badawy A. ANZ J Surg. 2019 Oct;89(10):1275-1280. doi: 10.1111/ans.15368. PMID: 31389123
  11. Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation. Iwaki K. Transplant Proc. 2019 Jul-Aug;51(6):1779-1784. doi: 10.1016/j.transproceed.2019.03.038. PMID: 31301855
  12. Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts. Macshut M. Liver Transpl. 2019 Oct;25(10):1524-1532. doi: 10.1002/lt.25601. PMID: 31298473
  13. Senescence caused by inactivation of the homeodomain transcription factor Pdx1 in adult pancreatic acinar cells in mice. Horiguchi M. FEBS Lett. 2019 Aug;593(16):2226-2234. doi: 10.1002/1873-3468.13504. PMID: 31240701
  14. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study. Nakamura N. BMC Cancer. 2019 Jun 25;19(1):621. doi: 10.1186/s12885-019-5825-8. PMID: 31238892
  15. Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury. Miyauchi T. Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13533-13542. doi: 10.1073/pnas.1820282116. PMID: 31196960
  16. Bolus Administration of Polyamines Boosts Effects on Hepatic Ischemia-Reperfusion Injury and Regeneration in Rats. Doi J. Eur Surg Res. 2019;60(1-2):63-73. doi: 10.1159/000497434. PMID: 31055575
  17. Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold. Minami T. Regen Ther. 2019 Mar 30;10:127-133. doi: 10.1016/j.reth.2019.03.002. PMID: 31032388
  18. Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma. Hamaguchi Y. Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. PMID: 31019900
  19. The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma. Morino K. Anticancer Res. 2019 Apr;39(4):2155-2161. doi: 10.21873/anticanres.13329. PMID: 30952762
  20. Laparoscopic Left Lateral Sectionectomy Using the Extrahepatic Glissonean Approach: A Secure Option for Achieving a Negative Margin for Lesions with Ductal Extension. Ogiso S. Ann Surg Oncol. 2019 Jun;26(6):1858. doi: 10.1245/s10434-019-07298-8. PMID: 30887372
  21. Significance of preoperative sarcopenia to liver surgery. Kaido T. Hepatobiliary Surg Nutr. 2019 Feb;8(1):59-62. doi: 10.21037/hbsn.2018.11.05. PMID: 30881967
  22. Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms. Masui T. Surg Today. 2019 Jul;49(7):593-600. doi: 10.1007/s00595-019-01779-9. PMID: 30838442
  23. Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. Yao S. Am J Transplant. 2019 Oct;19(10):2783-2794. doi: 10.1111/ajt.15337. PMID: 30830721.
  24. Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months. Nishino H. Am Surg. 2019 Feb 1;85(2):e111-e114. PMID: 30819321
  25. Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis. Hirata K. Sci Rep. 2019 Feb 7;9(1):1636. doi: 10.1038/s41598-018-38062-9. PMID: 30733468.
  26. Early post-operative intravenous tacrolimus in pediatric liver transplant recipients is not superior to oral tacrolimus. Sabra TA. Pediatr Transplant. 2019 May;23(3):e13368. doi: 10.1111/petr.13368. PMID: 30719833
  27. Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience. Iwamura S. Hepatol Res. 2019 Jun;49(6):687-694. doi: 10.1111/hepr.13320. PMID: 30698359
  28. Current state and future evolution of pancreatic islet transplantation. Anazawa T. Ann Gastroenterol Surg. 2018 Oct 8;3(1):34-42. doi: 10.1002/ags3.12214. PMID: 30697608
  29. Reappraisal of Prognostic Impact of Tumor SUVmax by 18F-FDG-PET/CT in Intrahepatic Cholangiocarcinoma. Yoh T. World J Surg. 2019 May;43(5):1323-1331. doi: 10.1007/s00268-019-04917-z. PMID: 30680501
  30. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Yao S. Clin Nutr. 2019 Dec;38(6):2770-2777. doi: 10.1016/j.clnu.2018.12.004. PMID: 30595376
  31. The Relationship Between 18F-FDG Uptake on PET/CT and Markers of Systemic Inflammatory Response in Patients Undergoing Surgery for Intrahepatic Cholangiocarcinoma. Seo S and Yoh T. Anticancer Res. 2019 Jan;39(1):341-346. doi: 10.21873/anticanres.13117. PMID: 30591478
  32. Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma. Ogawa K. J Hepatobiliary Pancreat Sci. 2019 Feb;26(2):73-81. doi: 10.1002/jhbp.602. PMID: 30561147
  33. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Kamo N. Clin Nutr. 2019 Oct;38(5):2202-2209. doi: 10.1016/j.clnu.2018.09.019. PMID: 30482562
  34. Efficiency of acoustic radiation force impulse imaging for the staging of graft fibrosis after liver transplantation. Yoshino K. Hepatol Res. 2019 Apr;49(4):394-403. doi: 10.1111/hepr.13289. PMID: 30471140
  35. Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma. Miyachi Y. World J Surg. 2019 Mar;43(3):920-928. doi: 10.1007/s00268-018-4861-x.PMID: 30465085
  36. Human Atrial Natriuretic Peptide in Cold Storage of Donation After Circulatory Death Rat Livers: An Old but New Agent for Protecting Vascular Endothelia? Nigmet Y. Transplantation. 2019 Mar;103(3):512-521. doi: 10.1097/TP.0000000000002552. PMID: 30461725
  37. Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection. Yoh T. Clin Cancer Res. 2019 Jan 15;25(2):619-628. doi: 10.1158/1078-0432.CCR-18-0124. PMID: 30352908
  38. Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. Ogiso S. HPB (Oxford). 2019 Jan;21(1):43-50. doi: 10.1016/j.hpb.2018.01.002. PMID: 30266496
  39. Optimal introduction of laparoscopic liver resection for Child-Pugh B. Fuji H. Asian J Endosc Surg. 2019 Jul;12(3):287-293. doi: 10.1111/ases.12634. PMID: 30133178
  40. Preventive Effect of Antioxidative Nutrient-Rich Enteral Diet Against Liver Ischemia and Reperfusion Injury. Miyauchi T. JPEN J Parenter Enteral Nutr. 2019 Jan;43(1):133-144. doi: 10.1002/jpen.1308. PMID: 29870084
  41. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Kobayashi A. Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555. PMID: 29064889
  42. A Propensity Score-Based Analysis of Laparoscopic Liver Resection for Liver Malignancies in Elderly Patients. Badawy A. J Invest Surg. 2019 Jan;32(1):75-82. doi: 10.1080/08941939.2017.1373170. PMID: 29039987